# reload+after+2024-01-21 01:27:23.609237
address1§520 Applewood Crescent
city§Vaughan
state§ON
zip§L4K 4B4
country§Canada
website§https://www.bausch.com
industry§Medical Instruments & Supplies
sector§Healthcare
longBusinessSummary§Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products for therapeutic use, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, dry eye, and redness relief. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of corneal, cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation is a subsidiary of Bausch Health Companies Inc.
fullTimeEmployees§13000
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Osama A. Eldessouky', 'age': 51, 'title': 'Executive VP & CFO', 'yearBorn': 1972, 'fiscalYear': 2022, 'totalPay': 1088925, 'exercisedValue': 0, 'unexercisedValue': 41538}, {'maxAge': 1, 'name': 'Dr. Yehia  Hashad M.D.', 'age': 56, 'title': 'Executive VP of Research & Development and Chief Medical officer', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 1094478, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Brenton L.  Saunders J.D.', 'age': 53, 'title': 'CEO & Chairman', 'yearBorn': 1970, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Alan  Waterhouse CPFA, MBA', 'age': 63, 'title': 'Executive VP and Chief Supply Chain & Operations Officer', 'yearBorn': 1960, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Frederick J. Munsch', 'age': 53, 'title': 'Senior VP, Controller & Chief Accounting Officer', 'yearBorn': 1970, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. A. Robert D. Bailey', 'age': 60, 'title': 'Executive VP & Chief Legal Officer', 'yearBorn': 1963, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jonathon L. Kellerman', 'title': 'Chief Compliance Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'T.J.  Crawford', 'title': 'Chief Communications Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Manisha A. Narasimhan Ph.D.', 'age': 46, 'title': 'Chief Corporate Development & Digital Officer', 'yearBorn': 1977, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Asli  Gevgilili', 'title': 'Executive VP & Chief Human Resources Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
priceToSalesTrailing12Months§1.456096
currency§USD
dateShortInterest§1702598400
forwardEps§0.86
pegRatio§4.64
exchange§NYQ
quoteType§EQUITY
shortName§Bausch + Lomb Corporation
longName§Bausch + Lomb Corporation
firstTradeDateEpochUtc§1651843800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§2dfa4f41-10d0-3324-be8e-f99a01abce5b
gmtOffSetMilliseconds§-18000000
targetHighPrice§28.08
targetLowPrice§26.74
targetMeanPrice§27.41
targetMedianPrice§27.41
recommendationMean§1.0
recommendationKey§strong_buy
numberOfAnalystOpinions§2
quickRatio§0.862
grossMargins§0.59661996
ebitdaMargins§0.14009
trailingPegRatio§None
